User profiles for Irene Cano-Pumarega

Irene Cano-Pumarega

Head of Sleep Unit. Ramon y Cajal Hospital, Madrid. Spain
Verified email at salud.madrid.org
Cited by 995

[HTML][HTML] [Translated article] International consensus document on obstructive sleep apnea

…, C Caballero-Eraso, I Cano-Pumarega… - Archivos de …, 2022 - Elsevier
The main aim of this international consensus document on obstructive sleep apnea is to provide
guidelines based on a critical analysis of the latest literature to help health professionals …

Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the Vitoria Sleep Cohort

I Cano-Pumarega, J Durán-Cantolla… - American journal of …, 2011 - atsjournals.org
Rationale: Obstructive sleep apnea and systemic hypertension (SH) are highly prevalent.
Although their association has been suggested in cross-sectional studies, conflicting evidence …

New concepts in the management of restless legs syndrome

D Garcia-Borreguero, I Cano-Pumarega - bmj, 2017 - bmj.com
Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED) is a neurological
condition with an overall prevalence in adults of 5-10% in Europe and North America. It is …

Sleep apnea and hypertension: are there sex differences? The Vitoria Sleep Cohort

I Cano-Pumarega, F Barbé, A Esteban… - Chest, 2017 - Elsevier
Background Evidence from longitudinal studies has reported contradictory results regarding
the association between OSA and hypertension. In a previous analysis of the Vitoria Sleep …

[HTML][HTML] Obstructive sleep apnea: emerging treatments targeting the genioglossus muscle

…, P Resano, I Cano-Pumarega… - Journal of clinical …, 2019 - mdpi.com
Obstructive sleep apnea (OSA) is characterized by repetitive episodes of upper airway
obstruction caused by a loss of upper airway dilator muscle tone during sleep and an inadequate …

Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis

…, X Guitart, CG Malo, I Cano-Pumarega… - Sleep medicine, 2018 - Elsevier
Objectives Recent animal models of restless legs syndrome (RLS) suggest that brain iron
deficiency is associated with a hypoadenosinergic state, with downregulation of adenosine A 1 …

Role of sleep apnea and long-term CPAP treatment in the prognosis of patients with melanoma: A Prospective Multicenter Study of 443 Patients

…, F Barbé, M Sanchez-de-la-Torre, I Cano-Pumarega… - Chest, 2023 - Elsevier
Background OSA has been associated with increased incidence and aggressiveness of
melanoma. However, the long-term impact of OSA and CPAP treatment on the prognosis of …

Emerging concepts of the pathophysiology and adverse outcomes of restless legs syndrome

S Romero-Peralta, I Cano-Pumarega… - Chest, 2020 - Elsevier
Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a common
neurological disorder affecting up to 5% to 10% of the population, but it remains an …

Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea

…, MF Troncoso, I Cano-Pumarega… - European …, 2018 - Eur Respiratory Soc
The goal of this study was to assess the relationship between the severity of obstructive sleep
apnoea (OSA) and the levels of carcinogenesis- and tumour growth-related biomarkers in …

Soluble PD-L1 is a potential biomarker of cutaneous melanoma aggressiveness and metastasis in obstructive sleep apnoea patients

…, V Cabriada-Nuño, I Cano-Pumarega… - European …, 2019 - Eur Respiratory Soc
Obstructive sleep apnoea (OSA) upregulates the programmed cell death-1 receptor and its
ligand (PD-L1) pathway, potentially compromising immunosurveillance. We compared …